B. Crestani (Paris, France), J. Chorostowska-Wynimko (Warsaw, Poland)
Positive association of PPARG2 and PPARGC1A gene polymorphisms with sarcoidosis susceptibility
M. Ales, I. Medica, B. Salobir, M. Tercelj, M. Sabovic, B. Peterlin (Ljubljana, Slovenia)
|    |
Positional cloning on 19q13 identifies UPAR as a potential asthma susceptibility gene
C. Browning, S. Barton, S. Bainbridge, S. Mutch, M. Rose-zerilli, A. Wheatley, I. Hall, S. Holgate, P. Tighe, J. Holloway, I. Sayers (Nottingham, Southampton, United Kingdom)
| |
Towards new antituberculotic targets: biochemical characterisation of mycobacterial RNase E/G
A. Csanadi, M. E. Zeller, A. Miczak, T. Rose, T. Bizebard, V. R. Kaberdin (Vienna, Austria; Szeged, Hungary; Paris, France)
| |
Transcriptional regulation of the human cystic fibrosis transmembrane conductance regulator gene promoter by peroxisome proliferator-activated receptor γ
A. Macdonald, D. Nahirney, M. Duszyk (Edmonton, AB, Canada)
| |
Promoter polymorphisms of cysteinyl leukotriene type 1 receptor in patients with severe asthma
M. Sokolowska, K. Wodz, M. Cieslak, M. L. Kowalski, R. Pawliczak (Lodz, Poland)
| |
Proteomic analysis of plasma from COPD patients and smoking control subjects
J. Bandow, J. Sepulveda, J. Baker, C. Painter, R. Hagler, K. Clarke, R. Ledley, I. James, I. Kilty, R. Van Bogelen (Ann Arbor, OH, Ann Arbor, MI, United States Of America; Sandwich, United Kingdom)
| |
Strain differences in hemodynamic, morphometric and gene expression responses to chronic hypoxia in mice
Y. Tada, C. Ivester, K. Miller, M. Carr, S. Laudi, T. Kuriyama, J. West (Chiba, Japan; Denver, CO, United States Of America)
| |
Metabonomic approach for noninvasive diagnosis of inflammatory lung diseases through nuclear magnetic resonance analysis of exhaled breath condensate
S. Heili-Frades, G. Peces-Barba, M. J. Rodriguez-Nieto, P. Villa-Valverde, D. Castejón, S. Perez-Rial, N. Hernandez, L. Del Puerto-Nevado, L. Martinez-Galan, J. Ruiz-Cabello, N. González-Mangado (Madrid, Spain)
| |